Closed Blood Sampling System Market is set to witness Huge Demand by 2031 | Smiths Medical, CardioMed Supplies Inc., Argon Medical Devices, Inc

Market Overview:

Closed blood sampling systems are needle-free devices used to collect blood samples from indwelling catheters or central venous access devices with minimal blood loss and negligible risk of contaminating the sample or exposing healthcare workers to blood-borne pathogens. They help reduce turnaround time for sample analysis and secure workflow in busy clinical settings.

Market Dynamics:

Closed blood sampling systems are gaining increasing demand owing to two main drivers - the rise in blood transfusion procedures and stringent safety regulations regarding blood collection practices. Blood transfusion therapies have grown in response to the increasing prevalence of chronic diseases, accidents, and trauma cases around the world. This has raised the volume of blood sampling activities and fueled adoption of more efficient sampling technologies. Furthermore, regulatory bodies have mandated the use of closed blood collection and sampling devices in hospitals to prevent exposure to biohazards and reduce operational costs associated with needlestick injuries. Closed systems help comply with safety norms in a cost-effective way while streamlining workflows.

Sample Pages of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/1642

Major Driver: Increasing Adoption of Safe Blood Collection Systems to Reduce Risk of Needle Stick Injuries

The global closed blood sampling system market is primarily driven by the increasing adoption of safe blood collection systems for reducing the risks associated with needle stick injuries. Conventional blood collection process involves direct insertion of needles into veins, which poses high risks of needle stick injuries to healthcare professionals. Sticker injuries often occur during recapping or disposing of used needles. According to World Health Organization (WHO), around three million healthcare workers experience percutaneous exposure to infectious diseases annually due to needle stick injuries. To address this issue and ensure occupational safety, hospitals and blood banks are increasingly adopting closed blood sampling systems equipped with safety-engineered blood collection needles. These systems feature automated safety mechanisms that enclose the needle immediately after blood collection, eliminating risks of accidental needle sticks. This helps prevent exposure to blood-borne pathogens like hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Growing awareness about benefits of closed blood sampling systems in reducing occupational hazards is a key factor driving the increased adoption.

Major Restrain: Limited Reimbursements for Needle Safety Devices

Limited or lack of reimbursements provided for needle safety devices like closed blood sampling systems act as a major restrain for the market. Healthcare reimbursement policies play a significant role in determining adoption of new medical technologies. However, reimbursements covering the additional costs associated with closed blood sampling systems compared to conventional setup are still limited across various regions. For instance, in the US which represents the largest market, Centers for Medicare and Medicaid Services (CMS) does not provide separate reimbursements for safety-engineered needle devices. Similarly in most developing regions, public health insurers do not cover costs of safety devices. This poses significant financial burden on hospitals, blood banks and other healthcare facilities to cover the incremental costs through their budgets. Limited reimbursements discourage higher uptake of closed blood sampling systems despite their clinical advantages. Unless reimbursement policies are aligned to promote use of safe blood collection devices, this factor will continue restricting growth opportunities for closed blood sampling system suppliers.

Top Companies Covered In This Report:

◘ Edwards Lifesciences Crop
◘ ICU Medical Inc.
◘ Smiths Medical
◘ CardioMed Supplies Inc.
◘ Argon Medical Devices Inc.
◘ Utah Medical Products Inc.
◘ fannin Ltd.
◘ Velano Vascular Inc.
◘ Ashcon International Inc.
◘ Merit Medical Systems
◘ Inc

Market Segmentation:

By Product Type:

Blood Sampling System
Blood Sampling Accessories

By Application:

Diagnostic
Treatment

By End Users:

Hospitals and Nursing Homes
Blood Banks
Surgical Clinics
Diagnostic Centers
Research and Academic Organizations
Others

Buy-Now and Get a Discount on this Report @ https://www.coherentmarketinsights.com/insight/buy-now/1642

Geographic Covered in the Report:

‣ North America (USA and Canada)
‣ Europe (UK, Germany, France and the rest of Europe)
‣ Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
‣ Latin America (Brazil, Mexico, and the rest of Latin America)
‣ Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Opportunity: Rising Investments in Medical Device Development in Developing Markets

Developing countries across Asia Pacific and Latin America currently present lucrative growth opportunities for players in the closed blood sampling system market. Healthcare infrastructures in emerging nations have witnessed significant investments over the past decade, aimed at improving medical facilities and ensure access to advanced treatment options. This rising investment focus on healthcare infrastructure development is also extending to areas of medical devices and hospital equipment procurement. As developing nations aim to achieve universal healthcare coverage and reduce disease burden, ensuring adoption of safety-engineered blood collection devices is gaining increased attention. Local governments as well as international development organizations are allocating funds to support procurement of devices that can help prevent infectious disease transmission and protect healthcare workers on duty. This creates significant opportunities for closed blood sampling system suppliers to gain foothold in emerging markets through technology transfer collaborations and favourable funding programs. With their large patient pools and growing healthcare access, developing countries will continue presenting lucrative prospects over the coming years.

Major Trend: Technology advancements towards automation and digitization

A key trend that is poised to significantly impact the closed blood sampling system market is the ongoing technological evolution towards automation and digitization. Players are increasingly focusing on developing 'intelligent' closed blood sampling solutions integrated with smart connectivity, big data analytics and artificial intelligence capabilities. Examples include automated sample collection devices with real-time tracking, error detection, workload scheduling and digital workflows. Such technologies help improve turnaround times, quality of care, cost-efficiencies as well as staff productivity. Vendors are also exploring innovative features like touchless actuations and pre-filled tubes in line with pandemic safety protocols. Further advancements in microfluidics, lab-on-chip designs and robotics could transform blood collection procedures. The growing digital imperative across all healthcare spheres will continue shaping the trajectory of the closed blood sampling system market going forward.

Reason to Buy this Report:

■ Study of the impact of technological developments on the market and the emerging trends shaping the industry in the coming years.
■ Analysis of the regulatory and policy changes affecting the market and the effects of these changes for market participants.
■ Summary of the competitive landscape in the Closed Blood Sampling System market, including profiles of the key players, their market share, and strategies for growth.
■Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth.
■Assessment of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants.

Questions Answered by the Report:

(1) Which are the dominant players of the Closed Blood Sampling System Market?
(2) What will be the size of the Closed Blood Sampling System Market in the coming years?
(3) Which segment will lead the Closed Blood Sampling System Market?
(4) How will the market development trends change in the next five years?
(5) What is the nature of the competitive landscape of the Closed Blood Sampling System Market?
(6) What are the go-to strategies adopted in the Closed Blood Sampling System Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/1642

Table of Contents

Chapter 1 Market Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Market Size Analysis from 2023 to 2030

Chapter 2 Competition by Types, Applications, and Top Regions and Countries
2.1 Market (Volume and Value) by Type
2.3 Market (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Worldwide Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Closed Blood Sampling System Sales, Consumption, Export, Import by Regions (2023-2023)
Chapter 5 North America Market Analysis
Chapter 6 Europe Market Analysis
Chapter 7 Middle East and Africa Market Analysis
Chapter 8 Asia Pacific Market Analysis
Chapter 9 Latin America Market Analysis
Chapter 10 Company Profiles and Key Figures in Closed Blood Sampling System Business
Chapter 11 Market Forecast (2023-2030)
Chapter 12 Conclusions

 🎯 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞Phone: U.S.: +1-206-701-6702
📞U.K.: +44-020-8133-4027
📞JAPAN: +81-50-5539-1737
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.